| |
| Issue |
Title |
| |
| No 6 (2025) |
Safety as a criterion for choosing an anticoagulant to prevent strokes and thromboembolism in patients with non-valvular atrial fibrillation |
Abstract
PDF (Rus)
|
|
E. P. Panchenko |
| |
| No 6 (2025) |
Challenges in the diagnosis of arrhythmogenic cardiomyopathy in an adolescent: Case report |
Abstract
PDF (Rus)
|
|
V. N. Komoliatova, S. R. Rodionovskaya, I. I. Kiseleva, V. G. Vinnikova, L. M. Makarov |
| |
| No 6 (2025) |
The role of inflammation, fibrosis, and metabolic stress in the formation and maintenance of atrial fibrillation |
Abstract
PDF (Rus)
|
|
T. V. Eliseeva, V. A. Tarasov, V. V. Salukhov |
| |
| No 16 (2024) |
Atrial fibrillation and multimorbidity: How to choose the perfect direct oral anticoagulant? |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. V. Dubinina, S. S. Telkova, A. I. Kochetkov, N. E. Gavrilova, E. Yu. Ebzeeva, A. V. Arablinskiy, O. A. Milovanova |
| |
| No 16 (2024) |
Acquired long QT interval syndrome as a predictor of sudden cardiac death: Causes, diagnostic criteria, and management strategy |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, V. V. Kolomytsev, L. V. Goryunova |
| |
| No 16 (2024) |
Biomarkers of risk and prognosis in atrial fibrillation |
Abstract
PDF (Rus)
|
|
I. A. Stepanenko, N. A. Mirzoyan, A. V. Ruban, D. I. Sopova, V. V. Salukhov, V. A. Tarasov |
| |
| No 6 (2024) |
Connection between сardiac fibrosis biomarkers and echocardiography parameters in patients with various forms of atrial fibrillation |
Abstract
PDF (Rus)
|
|
A. I. Kochetkov, I. Yu. Orlova, O. D. Ostroumova, M. V. Lopukhina, A. V. Starodubova, T. N. Korotkova, I. V. Vorozhko, A. V. Landa, A. I. Andrianov |
| |
| No 6 (2024) |
Рostural orthostatic tachycardia syndrome |
Abstract
PDF (Rus)
|
|
F. Kh. Orakova, I. K. Tkhabisimova, A. B. Khadzugov, R. A. Ligidova, K. Z. Kodzokova, Z. A. Mizieva, R. M. Alborova, M. R. Khazhkasimov, M. V. Makhmaeva, A. I. Vadaeva |
| |
| 1 - 8 of 8 Items |
|
